MEK/MELK inhibition and blood-brain barrier deficiencies in atypical teratoid/rhabdoid tumors.
Meel MH, Guillén Navarro M, de Gooijer MC, Metselaar DS, Waranecki P, Breur M, Lagerweij T, Wedekind LE, Koster J, van de Wetering MD, Schouten-van Meeteren N, Aronica E, van Tellingen O, Bugiani M, Phoenix TN, Kaspers GJL, Hulleman E.
Meel MH, et al. Among authors: aronica e.
Neuro Oncol. 2020 Jan 11;22(1):58-69. doi: 10.1093/neuonc/noz151.
Neuro Oncol. 2020.
PMID: 31504799
Free PMC article.